Insider · CIK 0001395277
Todd M Bluedorn
Files at TXN (TEXAS INSTRUMENTS INC), IOT (Samsara Inc.), MDLN (Medline Inc.). First filing Apr 27, 2026, latest Apr 27, 2026.
In brief
Todd M Bluedorn files SEC Form 4 as director at TXN (TEXAS INSTRUMENTS INC), and also at IOT (Samsara Inc.), MDLN (Medline Inc.). Since Apr 27, 2026, Todd M Bluedorn has reported 0 open-market buys worth $0 and 1 open-market sell worth $1.2M, the latest filed on Apr 27, 2026.
A track record needs three past buys with six months of prices behind them; Todd M Bluedorn has 0, so none is measured yet.
The newest scored trade: sold $1.2M of TXN on Apr 24, 2026, filed Apr 27, 2026, scored 50 (moderate). In the last 12 months: 0 buys worth $0 and 1 sell worth $1.2M.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
TXN: TEXAS INSTRUMENTS INC
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 50Moderate | TEXAS INSTRUMENTS INC | $1.2M 4,306 shares | -34% | +82% from low-2% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Apr 24, 2026 | TXN Texas Instruments | 4,306 0.00% of outstanding | $1.2M | Apr 24, 2026 | none |
Transactions
Every row this insider has filed, 11 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jul 22, 2026 | IOT Samsara Inc. | AGrant or award Class A Common Stock | +7,801 | $0.00 | $0 | 36,618 | Jul 24, 2026 |
| Dec 16, 2025 | MDLN Medline Inc. | AGrant or award Class A Common Stock | +10,345 | $0.00 | $0 | 10,345 | Jun 15, 2026 |
| Jun 11, 2026 | MDLN Medline Inc. | AGrant or award Class A Common Stock | +5,387 | $0.00 | $0 | 15,732 | Jun 15, 2026 |
| Apr 24, 2026 | TXN TEXAS INSTRUMENTS INC | MOption exercise Common Stock | +4,306 | $110.15 | $474k | 12,497 | Apr 27, 2026 |
| Apr 24, 2026 | TXN TEXAS INSTRUMENTS INC | SOpen-market sale Common Stock | -4,306 | $274.25 | $1.2M | 8,191 | Apr 27, 2026 |
| Apr 24, 2026 | TXN TEXAS INSTRUMENTS INC | MOption exercise NQ Stock Option (Right to Buy)derivative | -4,306 | $0.00 | $0 | 0 | Apr 27, 2026 |
| Jan 29, 2026 | TXN TEXAS INSTRUMENTS INC | AGrant or award Common Stock | +525 | $0.00 | $0 | 8,191 | Feb 2, 2026 |
| Jan 29, 2026 | TXN TEXAS INSTRUMENTS INC | AGrant or award NQ Stock Option (Right to Buy)derivative | +1,860 | $0.00 | $0 | 1,860 | Feb 2, 2026 |
| Jul 29, 2025 | IOT Samsara Inc. | AGrant or award Class A Common Stock | +6,371 | $0.00 | $0 | 28,817 | Jul 31, 2025 |
| Jan 27, 2025 | TXN TEXAS INSTRUMENTS INC | AGrant or award Common Stock | +614 | $0.00 | $0 | 7,666 | Jan 29, 2025 |
| Jan 27, 2025 | TXN TEXAS INSTRUMENTS INC | AGrant or award NQ Stock Option (Right to Buy)derivative | +2,551 | $0.00 | $0 | 2,551 | Jan 29, 2025 |
Questions about Todd M Bluedorn
Answered from the filings on this page, as of the latest one.
Is Todd M Bluedorn buying or selling?
In the last 12 months Todd M Bluedorn reported 0 open-market buys worth $0 and 1 open-market sell worth $1.2M on SEC Form 4; the latest was sold $1.2M of TXN on Apr 24, 2026. Grants, option exercises and tax withholding are not counted.
How did Todd M Bluedorn's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Todd M Bluedorn has 0.
Where does Todd M Bluedorn file Form 4?
Todd M Bluedorn has filed Form 4 at TXN (TEXAS INSTRUMENTS INC); IOT (Samsara Inc.); MDLN (Medline Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.